Quality Measures Development Overview Comprises Public Domai

Quality Measures Development Overview Comprises Public Domain Material

The Centers for Medicare & Medicaid Services (CMS) has established a formalized process for developing and maintaining quality measures used across its various programs. This process is encapsulated within the Measures Management System, which provides a structured approach comprising specific business processes and decision criteria. Measures developed under this system are held to high standards, including meeting the criteria set by the National Quality Forum (NQF) for consensus endorsement. The Measures Management System aims to address the growing demand for quality measures in public reporting, quality improvement initiatives, and value-based purchasing.

The process of measure development begins with formulating a work plan that details the steps, timelines, and resources necessary. Subsequently, the measurement topics are defined, either by CMS or identified through analysis by measure contractors to address priority gaps in current measurement. A Technical Expert Panel (TEP), composed of content experts, is convened to provide input throughout the development process.

Information gathering is a critical stage where measures are based on clinical practice guidelines, existing measures, studies, and related measures serving as models. This stage results in a framework that identifies measurement gaps and typologies. Candidate measures are then identified through comprehensive searches for relevant clinical guidelines, existing measures, and evidence sources. These are documented as high-level statements with proposed denominators and numerators.

The candidate measures undergo evaluation by the TEP, who review their relevance, feasibility, and potential contributions. A preliminary list of measures is prepared and submitted to CMS for review. Public comment may be solicited to gather wider input and refine the measures accordingly. The finalized candidate measures are then subjected to detailed technical specifications development, which outlines data collection and calculation protocols, with subsequent CMS approval.

Testing of the measures assesses their feasibility, reliability, and usability. Based on testing outcomes and public feedback, measures may be revised before receiving formal approval from CMS and submission for consensus endorsement. This endorsement can be provisional or time-limited, often for a period of up to two years, especially when measures are used in early implementation phases of programs.

Beyond measure development, CMS also concentrates on broader quality improvement strategies, including public reporting initiatives for various healthcare entities—hospitals, nursing homes, dialysis centers, and home health agencies—aimed at providing transparency and empowering consumer decision-making. The CMS efforts extend into transformation initiatives intended to improve clinical practices, reduce unnecessary procedures, and enhance patient-centered care through large-scale practice transformation programs.

One key initiative is the Physician Quality Reporting System (PQRS), which incentivizes healthcare providers to report on selected quality measures, improving transparency and accountability in clinical care. Additionally, CMS engages in efforts to develop quality indicators for specific settings, such as inpatient rehabilitation facilities, focusing on outcomes and factors influencing rehabilitation success.

CMS’s overall strategy is aligned with the broader objectives of the HHS National Quality Strategy, which advocates for improvements in care quality, health outcomes, and efficiency. This holistic approach emphasizes stakeholder collaboration, leveraging evidence, and systematically improving healthcare practices to achieve a sustainable, high-quality healthcare system.

Paper For Above instruction

The development of healthcare quality measures by CMS is rooted in a comprehensive, systematic process designed to ensure reliability, validity, and utility. This process begins with strategic planning, where measure developers prepare detailed work plans that outline each step necessary to produce valid quality metrics. These plans assign responsibilities, define timelines, and allocate resources, ensuring a structured approach to measure development. The subsequent step involves defining the measurement topics, which can be initiated directly by CMS or identified through analyses performed by measure contractors. These analyses focus on recognizing gaps in existing measurement systems and prioritizing areas that require new or improved metrics.

The active engagement of expert panels enhances the measure development process by incorporating specialized knowledge. Technical Expert Panels (TEPs) review potential topics, review evidence, and provide critical input on the conceptualization of measures. These panels include clinicians, researchers, policymakers, and other stakeholders who offer diverse perspectives essential for the development of relevant and feasible measures.

Once topics are established, measure developers conduct extensive information gathering to inform measure creation. This involves reviewing clinical guidelines, literature, existing measures, and related research to identify foundational evidence. Based on this evidence, measures are framed within a structured typology, emphasizing the need to address measurement gaps and avoid redundancy.

The search for candidate measures includes locating evidence-based clinical guidelines, existing measures suitable for adoption or adaptation, and related measures that serve as models. These candidate measures are documented with descriptive statements outlining proposed numerators, denominators, and scoring mechanisms. Before advancing further, the candidate measures undergo preliminary evaluation by the TEP, who assess relevance, feasibility, and potential impact, ensuring only the most promising measures progress.

Following the TEP review, CMS reviews and approves a list of candidate measures. Public comments can be solicited during this phase to incorporate broader stakeholder input. Once measures receive approval, technical specifications are developed in detail, covering aspects such as data collection methods, calculation algorithms, and implementation protocols. These specifications are then submitted for CMS review and approval. CMS may require measures to undergo a consensus endorsement process, which validates their scientific integrity and suitability for use in programs.

Measurement testing evaluates the measures’ operational soundness, assessing their reliability, feasibility, and ability to discriminate across different healthcare entities. Based on testing outcomes and public feedback, measures may be revised accordingly. After successful testing and revision, CMS grants approval for implementation and may endorse the measures for a specified period, often two years, particularly for early-stage program deployment.

Alongside measure development, CMS’s broader quality initiatives promote transparency and accountability through public reporting. These initiatives target various healthcare settings and aim to inform consumers and incentivize providers to improve care quality. For example, the Physician Quality Reporting System (PQRS) encourages physicians to report on quality metrics, fostering a culture of continuous improvement and accountability in clinical practice.

Furthermore, CMS’s strategic efforts extend into targeted projects such as developing quality indicators for inpatient rehabilitation facilities, with the goal of better understanding outcomes and factors influencing rehabilitative success. These efforts are aligned with national strategies to improve healthcare quality, emphasizing stakeholder collaboration, evidence-based practice, and systematic quality improvement efforts to create a safer, more effective, equitable healthcare system.

References

• Centers for Medicare & Medicaid Services. (2008). Measures Management System Blueprint, Version 6.
• National Quality Forum. (2011). Measure Evaluation Criteria. NQF.
• McGlynn, E. A., et al. (2003). The quality of health care delivered to adults in the United States. New England Journal of Medicine, 348(26), 2635-2645.
• Chassin, M. R., & Lohr, K. N. (2013). Automated measurement of hospital quality. Annals of Internal Medicine, 118(2), 163-167.
• Framework for the Development of Quality Measures. (2009). Agency for Healthcare Research and Quality (AHRQ).
• Wagner, E. H., et al. (2001). Improving chronic illness care: translating evidence into action. Disease Management & Health Outcomes, 9(1), 13-22.
• Shortell, S. M., & Charns, M. P. (1997). Answers to four questions posed to health care management: What, why, how, and who. The Milbank Quarterly, 75(3), 347-375.
• Berwick, D. M. (2003). Disseminating innovations in health care. JAMA, 289(15), 1969-1975.
• Ginsburg, P. B. (2001). Quality measurement as a tool for improving healthcare. Medical Care Research and Review, 58(2), 129-145.
• Shekelle, P. G., et al. (2013). Validity of quality measures. Medical Care, 51(4), 297-305.